FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1889063846> ?p ?o ?g. }

• W1889063846 endingPage "65" @default.
• W1889063846 startingPage "3156" @default.
• W1889063846 abstract "Resistance to tamoxifen (TAM) represents a significant challenge to the management of breast cancer. We previously reported that the estrogen receptor (ER)-negative hormone-independent T47D:C42 cell line has both elevated protein kinase Calpha (PKCalpha) protein expression and basal activator protein-1 activity compared with the parental ER+ (hormone-dependent) T47D:A18 cell line. Stable transfection of PKCalpha to the T47D:A18 breast cancer cell line results in increased basal activator protein-1 activity, reduced ER function, increased proliferation rate, and hormone-independent growth (Tonetti et al., Br. J. Cancer, 83: 782-791, 2000). In this report, we further characterize the role of PKCalpha overexpression in vivo to elucidate a possible molecular mechanism of tamoxifen resistance.To determine whether the T47D:A18/PKCalpha cell line would produce hormone-independent tumors in athymic mice, we injected T47D:A18, T47D:A18/neo, or the T47D:A18/PKCalpha20 cell clones bilaterally into the mammary fat pads of athymic mice. Tumor growth was evaluated following treatment with estradiol (E2), TAM, and the pure antiestrogen, ICI 182,780.Mice receiving either T47D:A18 or T47D:A18/neo cells produced tumors that grew in response to E2 treatment, whereas the untreated control and TAM-treated groups showed no tumor growth. Interestingly, mice receiving the T47D:A18/PKCalpha20 clone produced tumors in both the control and TAM groups, whereas tumor growth was inhibited in mice treated with E2. PKCalpha was also overexpressed in an MCF-7 tumor model that also exhibited TAM-stimulated and E2-induced regression.These results suggest that overexpression of PKCalpha in breast tumors results in hormone-independent tumor growth that cannot be inhibited by TAM treatment. Furthermore, the finding that E2 has an antitumor effect on breast tumors overexpressing PKCalpha is a novel observation that may have important therapeutic implications." @default.
• W1889063846 created "2016-06-24" @default.
• W1889063846 creator A5005296809 @default.
• W1889063846 creator A5032770196 @default.
• W1889063846 creator A5038887077 @default.
• W1889063846 creator A5049919852 @default.
• W1889063846 creator A5078049097 @default.
• W1889063846 date "2001-10-01" @default.
• W1889063846 modified "2023-10-01" @default.
• W1889063846 title "Novel antitumor effect of estradiol in athymic mice injected with a T47D breast cancer cell line overexpressing protein kinase Calpha." @default.
• W1889063846 cites W1576671418 @default.
• W1889063846 cites W1581064242 @default.
• W1889063846 cites W1606667357 @default.
• W1889063846 cites W166214193 @default.
• W1889063846 cites W1767727568 @default.
• W1889063846 cites W1944448503 @default.
• W1889063846 cites W1964957120 @default.
• W1889063846 cites W1967004332 @default.
• W1889063846 cites W1969969891 @default.
• W1889063846 cites W1980504987 @default.
• W1889063846 cites W1985549816 @default.
• W1889063846 cites W1987453246 @default.
• W1889063846 cites W1989314580 @default.
• W1889063846 cites W1991789148 @default.
• W1889063846 cites W1992905023 @default.
• W1889063846 cites W1997243786 @default.
• W1889063846 cites W2009489338 @default.
• W1889063846 cites W2022792151 @default.
• W1889063846 cites W2033014971 @default.
• W1889063846 cites W2046887108 @default.
• W1889063846 cites W2070944740 @default.
• W1889063846 cites W2078232516 @default.
• W1889063846 cites W2078462794 @default.
• W1889063846 cites W2081135713 @default.
• W1889063846 cites W2093363286 @default.
• W1889063846 cites W2095952487 @default.
• W1889063846 cites W2100907853 @default.
• W1889063846 cites W2106841768 @default.
• W1889063846 cites W2106898231 @default.
• W1889063846 cites W2109202868 @default.
• W1889063846 cites W2115220780 @default.
• W1889063846 cites W2131823783 @default.
• W1889063846 cites W2144347330 @default.
• W1889063846 cites W2148307287 @default.
• W1889063846 cites W2151808231 @default.
• W1889063846 cites W2315368724 @default.
• W1889063846 cites W2412428405 @default.
• W1889063846 cites W53823551 @default.
• W1889063846 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11595710" @default.
• W1889063846 hasPublicationYear "2001" @default.
• W1889063846 type Work @default.
• W1889063846 sameAs 1889063846 @default.
• W1889063846 citedByCount "19" @default.
• W1889063846 countsByYear W18890638462014 @default.
• W1889063846 countsByYear W18890638462015 @default.
• W1889063846 countsByYear W18890638462016 @default.
• W1889063846 countsByYear W18890638462017 @default.
• W1889063846 countsByYear W18890638462019 @default.
• W1889063846 countsByYear W18890638462021 @default.
• W1889063846 countsByYear W18890638462023 @default.
• W1889063846 crossrefType "journal-article" @default.
• W1889063846 hasAuthorship W1889063846A5005296809 @default.
• W1889063846 hasAuthorship W1889063846A5032770196 @default.
• W1889063846 hasAuthorship W1889063846A5038887077 @default.
• W1889063846 hasAuthorship W1889063846A5049919852 @default.
• W1889063846 hasAuthorship W1889063846A5078049097 @default.
• W1889063846 hasConcept C121608353 @default.
• W1889063846 hasConcept C126322002 @default.
• W1889063846 hasConcept C134018914 @default.
• W1889063846 hasConcept C1491633281 @default.
• W1889063846 hasConcept C150903083 @default.
• W1889063846 hasConcept C170493617 @default.
• W1889063846 hasConcept C207001950 @default.
• W1889063846 hasConcept C2776067312 @default.
• W1889063846 hasConcept C2777164284 @default.
• W1889063846 hasConcept C2777176818 @default.
• W1889063846 hasConcept C502942594 @default.
• W1889063846 hasConcept C530470458 @default.
• W1889063846 hasConcept C54355233 @default.
• W1889063846 hasConcept C55493867 @default.
• W1889063846 hasConcept C62112901 @default.
• W1889063846 hasConcept C71924100 @default.
• W1889063846 hasConcept C81885089 @default.
• W1889063846 hasConcept C84606932 @default.
• W1889063846 hasConcept C86803240 @default.
• W1889063846 hasConcept C88045685 @default.
• W1889063846 hasConceptScore W1889063846C121608353 @default.
• W1889063846 hasConceptScore W1889063846C126322002 @default.
• W1889063846 hasConceptScore W1889063846C134018914 @default.
• W1889063846 hasConceptScore W1889063846C1491633281 @default.
• W1889063846 hasConceptScore W1889063846C150903083 @default.
• W1889063846 hasConceptScore W1889063846C170493617 @default.
• W1889063846 hasConceptScore W1889063846C207001950 @default.
• W1889063846 hasConceptScore W1889063846C2776067312 @default.
• W1889063846 hasConceptScore W1889063846C2777164284 @default.
• W1889063846 hasConceptScore W1889063846C2777176818 @default.
• W1889063846 hasConceptScore W1889063846C502942594 @default.
• W1889063846 hasConceptScore W1889063846C530470458 @default.

• next